LCM
ABEO icon

Laurion Capital Management’s Abeona Therapeutics ABEO Stock Holding History

Laurion Capital Management’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-275,915
Closed -$1.57M – 234
2025
Q2 		$1.57M Sell
275,915
-1,030,674
-79% -$5.87M 0.03% 175
2025
Q1 		$6.22M Hold
1,306,589
– – 0.16% 95
2024
Q4 		$7.28M Hold
1,306,589
– – 0.13% 118
2024
Q3 		$8.26M Sell
1,306,589
-200,191
-13% -$1.05M 0.11% 85
2024
Q2 		$6.39M Buy
1,506,780
+859,950
+133% +$4.39M 0.08% 146
2024
Q1 		$4.69M Buy
+646,830
New +$4.1M 0.04% 262
2017
Q2 		– Sell
-2,216
Closed -$277K – 1594
2017
Q1 		$277K Buy
+2,216
New +$286K ﹤0.01% 1096

Other funds holding ABEO

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
WSL
Western Standard LLC Los Angeles, California $190M AUM 40.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return

Laurion Capital Management's ABEO Position: Q3 2025 in Review

Laurion Capital Management sold out of Abeona Therapeutics (ABEO) in Q3 2025, closing a stake of 275,915 shares — an estimated $1.57M sold.

Laurion Capital Management first reported a position in ABEO in Q1 2017 and held it in 7 quarters. The position peaked at $8.26M in Q3 2024. 100 funds tracked by Wall St. Rank hold ABEO as of Q3 2025.

  • Laurion Capital Management reported no remaining Abeona Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Laurion Capital Management sold 275,915 Abeona Therapeutics shares in Q3 2025, an estimated $1.57M.
  • Laurion Capital Management first reported a position in Abeona Therapeutics in Q1 2017 and held it in 7 quarters.
  • Laurion Capital Management's Abeona Therapeutics position peaked at $8.26M in Q3 2024.
  • 100 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q3 2025.

Based on Laurion Capital Management's 13F filing for Q3 2025, filed 17 Nov 2025.